EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Meta‐analysis of probiotics efficacy in the treatment of minimum hepatic encephalopathy

Yu-Lian Zhou, Shu-Tao Pu, Jian-Bo Xiao, Jun Luo, Li Xue iD

Liver International · 2024-12 · 44 (12) · 3164-3173

DOI: 10.1111/liv.16081 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Liver International, online erschienen am 12.09.2024. Verfasst von Yu-Lian Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang,…. Hauptthemen laut MEDLINE: Probiotics, Hepatic Encephalopathy, Randomized Controlled Trials as Topic, Ammonia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to systematically evaluate the efficacy of probiotics in treating minimum hepatic encephalopathy (MHE).

Methods

A systematic search was conducted across three major databases: PubMed, China National Knowledge Infrastructure and Wanfang. The search period spanned from the inception of each database to 9 March 2023. The objective was to identify all randomised controlled trials (RCTs) examining the efficacy of probiotic preparations in treating MHE. The search terms included ‘probiotics’ along with other clinically relevant terms to comprehensively capture all pertinent studies.

Results

A total of 18 RCTs were included. The meta‐analysis showed that probiotic treatment outperformed control groups in reducing blood ammonia levels (standard mean difference [MD] = −2.68, 95% confidence interval [CI]: −3.90 to −1.46, p < .0001), improving the remission rate of MHE (risk ratio [RR] = 2.79, 95% CI: 1.23–6.35, p = .01) and lowering alanine aminotransferase levels (MD = −11.10, 95% CI: −16.17 to −6.03, p < .0001). It also significantly reduced the Model for End‐Stage Liver Disease scores (MD = −2.55, 95% CI: −3.56 to −1.54, p < .00001) and the incidence of MHE (RR = .18, 95% CI: .09–.34, p < .00001).

Conclusion

Our study demonstrates that probiotics effectively improve blood ammonia levels, liver function and cognitive function in patients with MHE. They significantly enhance the remission rate of MHE and effectively reduce its incidence, providing solid new evidence for treating MHE with probiotics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsHepatic EncephalopathyRandomized Controlled Trials as TopicAmmoniaHumansTreatment OutcomeAlanine Transaminase

Stichwörter der Autor:innen

meta‐analysisminimum hepatic encephalopathyprobioticsrandomised controlled trial

Substanzen

AmmoniaAlanine Transaminase

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.

ORCID-Profile: Li Xue

Zitieren

APA

Zhou, Y. L., Pu, S. T., Xiao, J. B., Luo, J., & Xue, L. (2024). Meta‐analysis of probiotics efficacy in the treatment of minimum hepatic encephalopathy. Liver International, 44(12), 3164-3173. https://doi.org/10.1111/liv.16081

Vancouver

Zhou YL, Pu ST, Xiao JB, Luo J, Xue L. Meta‐analysis of probiotics efficacy in the treatment of minimum hepatic encephalopathy. Liver International. 2024;44(12):3164-3173. doi:10.1111/liv.16081

BibTeX
@article{Zhou2024,
  author = {Zhou, Yu-Lian and Pu, Shu-Tao and Xiao, Jian-Bo and Luo, Jun and Xue, Li},
  title = {Meta‐analysis of probiotics efficacy in the treatment of minimum hepatic encephalopathy},
  journal = {Liver International},
  year = {2024},
  volume = {44},
  number = {12},
  pages = {3164--3173},
  doi = {10.1111/liv.16081}
}
Kostenlos starten →